MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,134 | -14.2% | 413,417 | +6.6% | 0.01% | -13.3% |
| Q2 2023 | $4,819 | -46.3% | 387,674 | -39.5% | 0.02% | -51.6% |
| Q1 2023 | $8,972 | +33.1% | 640,432 | +35.9% | 0.03% | +24.0% |
| Q4 2022 | $6,742 | -99.9% | 471,145 | +17.6% | 0.02% | -41.9% |
| Q3 2022 | $10,232,000 | -15.3% | 400,781 | -5.8% | 0.04% | -18.9% |
| Q2 2022 | $12,085,000 | +15.3% | 425,379 | +43.1% | 0.05% | +32.5% |
| Q1 2022 | $10,483,000 | +80.1% | 297,229 | +113.9% | 0.04% | +81.8% |
| Q4 2021 | $5,821,000 | -16.1% | 138,930 | -1.7% | 0.02% | -24.1% |
| Q3 2021 | $6,940,000 | +20.8% | 141,400 | +2.7% | 0.03% | +7.4% |
| Q2 2021 | $5,746,000 | +55.3% | 137,684 | +32.7% | 0.03% | +42.1% |
| Q1 2021 | $3,699,000 | +113.3% | 103,790 | +67.9% | 0.02% | +90.0% |
| Q4 2020 | $1,734,000 | – | 61,814 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |